As of May 25th, we have reopened our office in Kyiv as the situation in the Ukrainian capital stabilises. The reopening is on a voluntary basis for employees and we are continuously reviewing the situation to ensure their safety. 

Our products remain available in approximately 80% of Ukraine.  For healthcare professionals and patients, we continue to support questions about product availability through our dedicated hotline (see below).

We have established a hotline for patients and healthcare providers in Ukraine to inform about the availability of our products. We will do our best to provide all necessary information.

  • 0-800-801-341 Toll-Free number in Ukraine
  • 032-246-50-73  Number in Ukraine (charges according to local operator)
  • +48-22-4444911 International number 
  • HOTLINE@novonordisk.com

As a pharmaceutical company, it is our responsibility to supply essential medicine to patients with chronic diseases, and we will do all we can to maintain supply in Ukraine and Russia.

With normal supply chains disrupted, we are in dialogue with several international humanitarian organizations to provide relief and have donated medicines and supplies to the Ukrainian Ministry of Health.

We are doing all we can to maintain the supply of essential medicines to patients living with chronic diseases in Ukraine.

We have donated up to two months' supply of life-saving medicine for diabetes and hemophilia from our current stock in Ukraine to the Ministry of Health.

We are in dialogue with several international humanitarian organizations to assess need for product donations. We are looking into different ways we can positively contribute including through our own supply chain capacity and expertise.  

We have suspended further marketing and clinical investments in Russia and are focusing our efforts to help our local employees and to ensure more than 700,000 patients can continue their treatment with our essential medication. The factory in Russia is still operating to supply medication to patients in Russia.

In Russia we are pausing starting new clinical trials and halting active enrollment of new patients, where there are currently more than 3,000 patients enrolled.

We are doing all we can to maintain the supply of essential medicines to patients living with chronic diseases in Ukraine.

We have donated up to two months' supply of life-saving medicine for diabetes and hemophilia from our current stock in Ukraine to the Ministry of Health. We are in dialogue with several international humanitarian organizations to assess need for product donations. We are looking into different ways we can positively contribute including through our own supply chain capacity and expertise.  

We’ve also established a hotline for patients and healthcare providers in Ukraine to inform about the availability of our products. We will do our utmost to provide all necessary information.

·        0-800-801-341 Toll-Free number in Ukraine

·        032-246-50-73  Number in Ukraine (charges according to local operator)

·        +48-22-4444911 International number 

·        HOTLINE@novonordisk.com

In addition, the Novo Nordisk Foundation has donated 8.2M USD to support the work of international relief organizations in receiving and assisting refugees, internally displaced people and other vulnerable groups with access to basic necessities such as food and shelter, health and protection. This includes the 750K USD donation announced at the start of the invasion to UNHCR – the UN’s refugee agency - to provide urgent support and protection to people forced to flee their homes.

We have sufficient stock of medicine in the Ukraine across the country, and we have expanded stock of medicines in the neighboring countries. 

We are doing all we can to maintain the supply of essential medicines to patients living with chronic diseases in Ukraine. We have donated life-saving medicine for diabetes and hemophilia from our current stock in Ukraine to the Ministry of Health, and we are in dialogue with several international humanitarian organizations to assess need for product donations. 

Our warehouse in Ukraine is still in operation. However, deliveries have been and will be impacted due to shortages in driving staff. We are doing everything we can to get medicines to patients that need them either through pharmacies or humanitarian organizations.

 

In case the usual supply channels for our medicines get disrupted due to unstable situations in a country, we always aim to partner with local health authorities and humanitarian organizations who have capacity for providing relief on the ground. We are also in dialogue with several international humanitarian organizations to assess the need for product donations. 

We have donated up to two months supply of life-saving medicine for diabetes and hemophilia from our current stock in Ukraine to the Ministry of Health.

The Novo Nordisk Foundation has donated 8.2M USD to support the work of international relief organizations in receiving and assisting refugees, internally displaced persons and other vulnerable groups with access to basic necessities such as food and shelter, health and protection. This includes a 750K USD donation announced at the start of the invasion to UNHCR – the UN’s refugee agency - to provide urgent support and protection to people forced to flee their homes.

Novo Nordisk has donated life-saving medicine for diabetes and hemophilia from our current stock in Ukraine to the Ministry of Health. We are in dialogue with several international humanitarian organizations to assess need for product donations. We are looking into different ways we can positively contribute, incl. through own supply chain capacity and expertise.